EMR vs PH
Emerson Electric and Parker Hannifin, both Industrials
Parker Hannifin is the larger company at $120B against $84B. On trailing earnings EMR is the cheaper of the two at a P/E of 34.6 against 36.5, a gap that is only a bargain if the two are growing at similar rates. Over the past year PH returned +50% against +20% for EMR. Ryufin's sector-relative Smart Score puts PH ahead, 8/10 against 5/10.
| Figure | EMR | PH |
|---|---|---|
| Last close | $158 | $1039 |
| Market cap | $84B | $120B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 34.6 | 36.5 |
| Dividend yield | 1.3% | 0.6% |
| 1-year return | +20% | +50% |
| 5-year return | +73% | +255% |
| Ryufin Smart Scoresector-relative, 1–10 | 5/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Emerson Electric
Revenue of $4.9B in Q3 2026, net income $718M. Its largest reported line is Final Control, 33% of the disclosed total.
Parker Hannifin
Revenue of $5.8B in Q4 2026, net income $1.1B. Its largest reported line is Filtration And Engineered Materials, 28% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.